biosig_rgb.png
BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization
24 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022
19 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 19, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
biosig_rgb.png
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference
13 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer
11 oct. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, Oct. 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Earth Science Tech,
Earth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical Device
03 août 2017 08h35 HE | Earth Science Tech, Inc.
Hollywood, FL, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid,...
biosig_rgb.png
BioSig Technologies Enters into Strategic Development Work with Health Research International
11 juil. 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology
27 juin 2017 08h00 HE | Nu-Med Plus, Inc.
SALT LAKE CITY, UT--(Marketwired - June 27, 2017) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field,...
biosig_rgb.png
Novel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017
26 juin 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, June 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget
13 juin 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, June 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...
biosig_rgb.png
BioSig Technologies Launches New Corporate Website
08 juin 2017 08h00 HE | BioSig Technologies, Inc.
Minneapolis, MN, June 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...